About the Event
In this installment of the Department of Ophthalmology and Mitchel and Shannon Wong Eye Institute’s Continuing Medical Education Series, David Brown, M.D., FACS, presents “Optical Coherence Tomography on Earth and in Space.” Brown is a clinical instructor in the Department of Ophthalmology at Baylor College of Medicine. He serves as director for the Greater Houston Retina Consultants of Texas.
In-person attendees are encouraged to attend at 6 p.m. for a reception prior to the lecture that begins at 6:30 p.m.
Email Nicole Groote for more information.
Learning Objectives
By the end of this presentation, the audience participant should be able to:
- Describe how to recognize/diagnose posterior vitreous detachment status with the RNFL OCT scan.
- Discuss how optical coherence tomography of the nerve and macula can guide diagnosis/treatment of cystoid macular edema, drug toxicity and other commonly encountered clinical pathologies.
- Outline the pathophysiologic changes occurring to the choroid and ocular structures in astronauts on long-term space flight missions.
Target Audience
- Primary: Physicians in ophthalmology
- Secondary: Any discipline physicians and physician extenders
Attributes/Competencies
This activity has been designed to promote some of the following desired physician attributes and competencies:
- ACGME: Patient Care, Interpersonal and Communication Skills, Professionalism, Medical Knowledge, Practice-Based Learning and Improvement Systems-Based Practice
- IOM: Patient-Centered Care, Work with Interdisciplinary Teams, Use Evidence-Based Practice, Apply Quality Improvement, Use informatics
- IECC: Interprofessional Teamwork and Team-Based Practice, Interprofessional Communication, Roles and Responsibilities
Speaker Disclosure
David Brown, M.D., FACS, speaker for this educational activity, received consulting fees/honoraria for ongoing services for AbbVie, Annexon, Apellis , Bayer, Boehringer Ingelheim, Celltrion, Clearside, Kodiak, Kowa Ocular Therapeutix, Opus (formerly Ocuphire), OPTOS, Ray, Regeneron, RetinAI, Samsung Bioepis, Senju, Stealth and Topcon. He received grants for ongoing research support as a principal investigator for trials sponsored by AffaMed, Annexon, Apellis, Bayer, Boehringer Ingelheim, Eyebiotech, EyePoint, Genentech, i-Lumen, Kodiak, Kyoto DDD, Kyowa Kirin, Novartis, Ocular Therapeutix, Oculis, OcuTerra, Opthea, OPTOS, Outlook Therapeutics, Regeneron, Roche, Shanghai Henlius and Stealth. He is a patent beneficiary of OPTOS. He holds stock options in Adverum, Clearside and Opus (formerly Ocuphire).
Planner Disclosure
Jane Edmond, M.D.; Eric Crowell, M.D., MPH; and Nicole Groote, planners of this educational activity, have no relevant relationship(s) with ineligible companies to disclose.
The CME Advisory Committee, reviewers of this educational activity, have no relevant relationships with ineligible companies to disclose.
Accreditation Statement
The University of Texas at Austin Dell Medical School is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
The University of Texas at Austin Dell Medical School designates this internet live course for a maximum of 1.00 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.